Filing Details
- Accession Number:
- 0001209191-21-019596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-10 18:18:58
- Reporting Period:
- 2021-03-08
- Accepted Time:
- 2021-03-10 18:18:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1659085 | Gary Sender | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-08 | 15,885 | $5.31 | 15,885 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-08 | 12,890 | $17.00 | 28,775 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-08 | 28,775 | $66.55 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-08 | 15,885 | $0.00 | 15,885 | $5.31 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-08 | 12,890 | $0.00 | 12,890 | $17.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,246 | 2029-08-01 | No | 4 | M | Direct | |
| 19 | 2030-02-05 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.50 to $66.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- The option was granted on August 1, 2019. The shares underlying the option vested with respect to 25% of the shares on July 22, 2020 and the remainder are scheduled to vest in equal monthly installments through July 22, 2023.
- The option was granted on February 5, 2020 and is fully vested.
Billionaire Hedge Funds
